N04BD02 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	10

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

diseases per page:

Showing 1 to 10 of 10 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-015161-31-PL (EUCTR)	08/06/2011	23/02/2011	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 15.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Product Name: Prela ...	Schering-Plough Research Institute, a division of Schering Corporation	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	United States;Portugal;Finland;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Italy;I ...
2	EUCTR2009-015161-31-DE (EUCTR)	04/04/2011	24/08/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Product Name: Prela ...	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. Inc.	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	Portugal;United States;Finland;Spain;Turkey;Austria;Israel;Russian Federation;Italy;United Kingdom;I ...
3	EUCTR2009-015161-31-GB (EUCTR)	07/03/2011	01/07/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.	NULL	Not Recruiting			Female: yes Male: yes	750	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Portugal;United States;Finland;Spain;Turkey;Austria;Israel;Russian Federation;Italy;United Kingdom;I ...
4	EUCTR2009-015161-31-BG (EUCTR)	17/02/2011	02/02/2011	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	Portugal;United States;Finland;Spain;Turkey;Austria;Israel;Russian Federation;Italy;United Kingdom;I ...
5	EUCTR2009-015161-31-PT (EUCTR)	28/01/2011	29/10/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	United States;Portugal;Finland;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Italy;I ...
6	EUCTR2009-015161-31-CZ (EUCTR)	17/01/2011	28/07/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 15.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Schering-Plough Research Institute, a division of Schering Corporation	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	United States;Portugal;Finland;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Italy;I ...
7	EUCTR2009-015161-31-NL (EUCTR)	09/12/2010	09/08/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Schering-Plough Research Institute, a division of Schering Corporation	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	France;Czech Republic;Canada;Poland;Brazil;Peru;Bulgaria;Netherlands;Germany;Sweden;United States;Po ...
8	EUCTR2009-015161-31-SE (EUCTR)	02/12/2010	06/10/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Schering-Plough Research Institute, a division of Schering Corporation	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	United States;Portugal;Finland;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Italy;I ...
9	EUCTR2009-015161-31-AT (EUCTR)	03/11/2010	17/08/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Schering-Plough Research Institute, a division of Schering Corporation	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	United States;Portugal;Finland;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Italy;I ...
10	EUCTR2009-015161-31-FI (EUCTR)	17/08/2010	23/06/2010	A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson' ...	A Phase 3, 12-Week, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Efficacy and Safety S ...	Parkinson's disease MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Preladenant Product Code: SCH 420814 INN or Proposed INN: Preladenant Trade Name: Azilect ...	Schering-Plough Research Institute, a division of Schering Corporation	NULL	Not Recruiting			Female: yes Male: yes	750	Phase 3	United States;Portugal;Finland;Spain;Turkey;Austria;Russian Federation;Israel;United Kingdom;Italy;I ...

First Previous1Next Last